Celerion has added a containment room at the Belfast, Northern Ireland facility that will allow the company to develop programs that require studies using biologics and vaccines with primary and secondary containment. The containment room is a modular facility with a negative pressure processing room that houses a Biosafety Level (BSL-2) cabinet, enabling the processing of live class 2 and class 3 biologics.   “The addition of the containment room, coupled with our ability in the Belfast clinic ...